ESC Premium Access

Introduction - Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure.

Topic: Primary cardiovascular prevention: interventions and outcomes
Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Boehringer Ingelheim/Lilly

Congress Presentation

About the speaker

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
50 presentations
3 followers

2 more presentations in this session

SGLT2 inhibition in cardiology: what a cardiologist needs to know.

Speaker: Professor N. Sattar (Glasgow, GB)

Thumbnail

Panel discussion; SGLT2 in clinical cardiology.

Speaker: Professor S. Anker (Berlin, DE) Professor N. Sattar (Glasgow, GB) Professor J. Deanfield (London, GB) Doctor D. Fitchett (Toronto, CA)

Thumbnail

Access the full session

Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)

Speakers: Professor J. Deanfield, Professor N. Sattar, Professor S. Anker, Professor N. Sattar, Professor J. Deanfield...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb